← All Immunocore Holdings PLC filings

Immunocore Holdings PLC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
IMCR
Immunocore Holdings PLC
DEF: Immunocore 2026 Annual General Meeting Proxy Statement
Immunocore Holdings plc has issued its proxy statement for the 2026 Annual General Meeting to be held on May 27, 2026.
NASDAQ
IMCR
Immunocore Holdings PLC
DEF: Immunocore Holdings Sets Date for 2025 Annual General Meeting, Seeks Shareholder Approval on Key Proposals
Immunocore Holdings announces its 2025 Annual General Meeting (AGM) to be held on May 15, 2025, seeking shareholder votes on director re-appointments, executive compensation, auditor ratification, and share issuance authorizations.
NASDAQ
IMCR
Immunocore Holdings PLC
DEF 14A: Immunocore Holdings Sets Date for 2024 Annual General Meeting, Outlines Key Proposals
Immunocore Holdings announces its 2024 Annual General Meeting (AGM) to be held on May 23, 2024, featuring proposals for director re-appointments, executive compensation approval, auditor ratification, and adoption of new articles of association.